Gene · 10890
Papers1,621
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,621
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| UNC-116 and UNC-16 function with the NEKL-3 kinase to promote axon targeting. | Development | 2023 | 37756604 | PubTator, text mining | PubMed |
| CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis. | Elife | 2023 | 37737843 | PubTator, text mining | PubMed |
| RAB10 promotes breast cancer proliferation migration and invasion predicting a poor prognosis for breast cancer. | Sci Rep | 2023 | 37709911 | PubTator, text mining | PubMed |
| Leucine-rich repeat kinase 2 at a glance. | J Cell Sci | 2023 | 37698513 | PubTator, text mining | PubMed |
| Exercise training attenuates skeletal muscle fat infiltration and improves insulin pathway of patients with immune-mediated necrotizing myopathies and dermatomyositis. | Arch Rheumatol | 2023 | 37680507 | PubTator, text mining | PubMed |
| CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study. | mBio | 2023 | 37655880 | PubTator, text mining | PubMed |
| Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis. | Medicine (Baltimore) | 2023 | 37653757 | PubTator, text mining | PubMed |
| Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy. | Pharmaceutics | 2023 | 37631265 | PubTator, text mining | PubMed |
| Inhibition of the Exocyst Complex Attenuates the LRRK2 Pathological Effects. | Int J Mol Sci | 2023 | 37628835 | PubTator, text mining | PubMed |
| Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts. | BMC Nephrol | 2023 | 37626301 | PubTator, text mining | PubMed |
| Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes. | J Biol Chem | 2023 | 37625589 | PubTator, text mining | PubMed |
| Arrestin domain-containing protein 1-mediated microvesicles (ARMMs) protect against cadmium-induced neurotoxicity. | Extracell Vesicle | 2023 | 37614814 | PubTator, text mining | PubMed |
| Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression. | Sci Rep | 2023 | 37596305 | PubTator, text mining | PubMed |
| The mitophagy pathway and its implications in human diseases. | Signal Transduct Target Ther | 2023 | 37582956 | PubTator, text mining | PubMed |
| Cross-family small GTPase ubiquitination by the intracellular pathogen Legionella pneumophila. | bioRxiv | 2023 | 37577546 | PubTator, text mining | PubMed |
| Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models. | Curr Res Neurobiol | 2023 | 37576491 | PubTator, text mining | PubMed |
| High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation. | J Cancer | 2023 | 37576392 | PubTator, text mining | PubMed |
| Exocytosis of Nanoparticles: A Comprehensive Review. | Nanomaterials (Basel) | 2023 | 37570533 | PubTator, text mining | PubMed |
| The Golgi Apparatus: A Voyage through Time, Structure, Function and Implication in Neurodegenerative Disorders. | Cells | 2023 | 37566051 | PubTator, text mining | PubMed |
| CircECE1 promotes osteosarcoma progression through regulating RAB3D by sponging miR-588. | J Orthop Surg Res | 2023 | 37559140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10890/papers?page=9